Literature DB >> 8576177

Functional characterization of the human factor VII 5'-flanking region.

E S Pollak1, H L Hung, W Godin, G C Overton, K A High.   

Abstract

Factor VII is a vitamin K-dependent coagulation protein essential for proper hemostasis. The human Factor VII gene spans 13 kilobase pairs and is located on chromosome 13 just 2.8 kilobase pairs 5' to the Factor X gene. In this report, we show that Factor VII transcripts are restricted to the liver and that steady state levels of mRNA are much lower than those of Factor X. The major transcription start site is mapped at -51 by RNase protection assay and primer extension experiments. The first 185 base pairs 5' of the translation start site are sufficient to confer maximal promoter activity in HepG2 cells. Protein binding sites are identified at nucleotides -51 to -32, -63 to -58, -108 to -84, and -233 to -215 by DNase I footprint analysis and gel mobility shift assays. A liver-enriched transcription factor, hepatocyte nuclear factor-4 (HNF-4), and a ubiquitous transcription factor, Spl, are shown to bind within the first 108 base pairs of the promoter region at nucleotide sequences ACTTTG and CCCCTCCCCC, respectively. The importance of these binding sites in promoter activity is demonstrated through independent functional mutagenesis experiments, which show dramatically reduced promoter activity. Transactivation studies with an HNF-4 expression plasmid in HeLa cells also demonstrate the importance of HNF-4 in promoting transcription in non-hepatocyte derived cells. Additionally, the sequence of a naturally occurring allele containing a previously described decanucleotide insert polymorphism at -323 is shown to reduce promoter activity by 33% compared with the more common allelic sequence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576177     DOI: 10.1074/jbc.271.3.1738

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Genotyping on a thermal gradient DNA chip.

Authors:  Tomoharu Kajiyama; Yuji Miyahara; Larry J Kricka; Peter Wilding; David J Graves; Saul Surrey; Paolo Fortina
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

2.  Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements.

Authors:  H Nakshatri; P Bhat-Nakshatri
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

Review 3.  Regulatory polymorphisms underlying complex disease traits.

Authors:  Julian C Knight
Journal:  J Mol Med (Berl)       Date:  2004-12-09       Impact factor: 4.599

4.  Association of ACE and FACTOR VII gene variability with the risk of coronary heart disease in north Indian population.

Authors:  R C Sobti; Nishi Maithil; Hitender Thakur; Yashpaul Sharma; K K Talwar
Journal:  Mol Cell Biochem       Date:  2010-04-03       Impact factor: 3.396

5.  Hepatocyte nuclear factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases.

Authors:  Shiro Koizume; Naho Yokota; Etsuko Miyagi; Fumiki Hirahara; Yoshiyasu Nakamura; Yuji Sakuma; Akira Yoshida; Yoichi Kameda; Eiju Tsuchiya; Wolfram Ruf; Yohei Miyagi
Journal:  Mol Cancer Res       Date:  2009-12-08       Impact factor: 5.852

6.  Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men.

Authors:  G Ken-Dror; F Drenos; S E Humphries; P J Talmud; A D Hingorani; M Kivimäki; M Kumari; K A Bauer; J H Morrissey; H A Ireland
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

7.  Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression.

Authors:  Yusuke Inoue; Luanne L Peters; Sun Hee Yim; Junko Inoue; Frank J Gonzalez
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

8.  The decanucleotide polymorphism in the factor VII promoter predicts factor VII plasma levels but not the risk of acute coronary syndromes.

Authors:  E Jimenez-Boj; J Schüttrumpf; E Forberg; H H Watzke; K Huber
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

Review 9.  Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  World J Clin Oncol       Date:  2014-12-10

10.  Population genetic and phylogenetic evidence for positive selection on regulatory mutations at the factor VII locus in humans.

Authors:  Matthew W Hahn; Matthew V Rockman; Nicole Soranzo; David B Goldstein; Gregory A Wray
Journal:  Genetics       Date:  2004-06       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.